Antonio Waldo Zuardi, MD, PhD

home / authors / antonio-waldo-zuardi-md-phd

Articles

Exploring the Relationship Between Cannabidiol and Psychosis

Exploring the Relationship Between Cannabidiol and Psychosis

Antonio Waldo Zuardi, MD, PhD;José Alexandre Crippa, MD, PhD

September 28th 2020

The acute psychotomimetic effect of cannabis is transitory, but evidence indicates that the chronic use, especially if started in adolescence, contributes to the occurrence of schizophrenia.

Understanding the Relationship Between Cannabidiol and Psychosis: Clinical Issues

Understanding the Relationship Between Cannabidiol and Psychosis: Clinical Issues

Antonio Waldo Zuardi, MD, PhD;José Alexandre Crippa, MD, PhD

Drs Zuardi and Crippa discuss the current stage of scientific evidence that supports the use of cannabidiol in schizophrenia, anxiety, and Parkinson disease.

Latest Updated Articles

Mini Quiz: Treatment for Pedophilia?

Published: March 19th 2021 | Updated: July 3rd 2025

Mini Quiz: Treatment for Pedophilia?

Poor DSM-5—So Misunderstood!

Published: March 23rd 2021 | Updated: July 3rd 2025

Poor DSM-5—So Misunderstood!

Meyer

Published: May 21st 2025 | Updated: July 3rd 2025

Use of Plasma Levels of Antipsychotics: A Conversation With Jonathan M. Meyer, MD, DLFAPA

Newcorn

Published: May 21st 2025 | Updated: July 3rd 2025

Assessing Adult ADHD: A Conversation With Jeffrey Newcorn, MD

John Krystal

Published: May 21st 2025 | Updated: July 3rd 2025

A Shift in the Way We Think About the Biology of Depression: A Conversation With John H. Krystal, MD

McIntyre

Published: May 22nd 2025 | Updated: July 3rd 2025

Insulin Is an Antidepressant: A Conversation With Roger McIntyre, MD, FRCPC

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.